Latest news in Pharmaceuticals
Ironwood Pharmaceuticals Prices Public Offering of Common Stock
9 Feb 2012
Ironwood Pharmaceuticals, Inc. announced today the pricing of an underwritten public offering of 5,250,000 shares of its Class A common stock at a price of $15.09 per share to the public.9 Feb 2012
SAN DIEGO, Feb. 9, 2012 /PRNewswire/ --Â Cadence Pharmaceuticals, Inc. (NASDAQ: CADX - News), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally ...Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2011 Financial Results
9 Feb 2012
Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and full year 2011, andIn this category: Websites: 0, Number of pages: 0, Last updated: 10 Feb 2012